Medical Therapy In Type B Aortic Intramural Hematoma: A Very Recent Single-Center Experience

C. Calanni Macchio,A. Damiano,A. Milione,E. Mileo,E. Lonardo,S. H. B. Hamameh,G. Pisapia,L. Di Tommaso
DOI: https://doi.org/10.2459/01.jcm.0001096188.32069.a6
IF: 2.43
2024-12-13
Journal of Cardiovascular Medicine
Abstract:Type B intramural hematoma (TBIMH) management is unclear. Recent guidelines recommend optimal medical therapy (OMT) for stable cases without high-risk signs, closely monitoring evolution with regular imaging follow-ups. OMT and elective TEVAR are suggested for high-risk patients and emergent TEVAR for complicated IMH. In this single-center retrospective series, we report our experience of OMT failure.
cardiac & cardiovascular systems
What problem does this paper attempt to address?